Dr. Schiopu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Rheumatology, 2003 - 2005
University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1997
Certifications & Licensure
GA State Medical License 2022 - 2025
MI State Medical License 2002 - 2025
NJ State Medical License 2005 - 2009- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 3 citationsRiociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial.Oliver Distler, Yannick Allanore, Christopher P Denton, Masataka Kuwana, Marco Matucci-Cerinic
The Lancet. Rheumatology. 2023-11-01 - 46 citationsThe American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis: ACR Provisional Composite ...Dinesh Khanna, Veronica J. Berrocal, Edward H. Giannini, James R. Seibold, Peter A. Merkel
Arthritis Care & Research. 2016-02-01 - 142 citationsAbatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled TrialDinesh Khanna, Cathie Spino, Sindhu R. Johnson, Lorinda Chung, Michael L. Whitfield
Arthritis & Rheumatology. 2020-01-01
Press Mentions
- Rheumatic Manifestations of Diabetes (Mimics, Common Culprits & More)November 11th, 2024
We Know Too Little About Vaccines in Patients with Inflammatory DiseasesApril 14th, 2023- Diagnosing & Caring for Patients with FibromyalgiaMay 19th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
